Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Big Easy Weight Loss vs GoodRx

Big Easy Weight Loss
Graded #56

Higher grade

vs+5.700000000000003
GoodRx
Graded #116

Lower grade

The verdict

Big Easy Weight Loss takes it — 75.3/100 to 69.6/100.

Big Easy Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Big Easy Weight Loss (joinbigeasy.com) is a New Orleans MD-run telehealth that ships compounded GLP-1 medication nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBig Easy Weight Loss +9
89
80
Dose & formulationBig Easy Weight Loss +2
72
70
Clinical oversightBig Easy Weight Loss +9
78
69
Labs & monitoringBig Easy Weight Loss +1
52
51
FulfillmentBig Easy Weight Loss +9
90
81
Contract termsEven
55
55
Big Easy Weight Loss · left barGoodRx · right bar

The numbers

MetricBig Easy Weight LossGoodRx
WeighScore75.3/10069.6/100
GradeCC
Scorecard rank#56#116
Semaglutide$133/mo (all doses, compounded)Not disclosed
Tirzepatide$166/mo (all doses, compounded)$299/mo (brand Zepbound)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Big Easy Weight Loss

Graded #56 · C

Strengths

  • Low pricing: about 133 dollars per month for semaglutide, 166 for tirzepatide
  • Site states it serves all 50 states with a 2 to 3 day pharmacy turnaround
  • Names its partner compounding pharmacies and a Chief Medical Officer

Where it loses points

  • Priced as 10 to 12-week packages rather than a simple monthly fee
  • New-patient pricing is promotional and may rise on renewal
GoodRx

Graded #116 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard